Latest News for: evx

Edit

Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 ...

Nasdaq Globe Newswire 03 Oct 2026
EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel ...
Edit

Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting (Form 6-K) (Evaxion A/S)

Public Technologies 02 Oct 2026
The new data will reflect the systemic immunomodulatory effects of EVX-01 plus pembrolizumab beyond vaccine-specific T-cell responses using comprehensive immune profiling ... EVX-01 ... About EVX-01.
Edit

Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1 (Form 6-K) (Evaxion A/S)

Public Technologies 13 Jul 2026
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1 The new data demonstrates the potential to improve control of acute infection, latency, and viral reactivation, further ...
Edit

Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1

The Daily Record - Dunn 12 Jul 2026
The new data demonstrates the potential to improve control of acute infection, latency, and viral reactivation, ....
Edit

Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1 (Evaxion A/S)

Public Technologies 12 Jul 2026
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1. The new data demonstrates the potential to improve control of acute infection, latency, and viral reactivation, further supporting the concept behind EVX-V1.
  • 1

Article Search

tools
×
×
×
×